PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Symptom | |diabetes |
| Sentences | 196 |
| PubMedID- 26251624 | The development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm) may be due to hypercoagulability and platelet hyperaggregability,1,2 along with increased levels of platelet activation markers. |
| PubMedID- 26223257 | The jpad study (japanese primary prevention of atherosclerosis with aspirin for diabetes) analyzed the effect of asa, 81–100 mg, in patients with type 2 diabetes in primary prevention of atherosclerotic events. |
| PubMedID- 24739603 | These findings suggest that measuring the hemoglobin level is clinically relevant for estimating the risk of atherosclerosis in patients with diabetes categorized according to the tg-hdl ratio. |
| PubMedID- 25471794 | Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in apoe-null mice. |
| PubMedID- 21779189 | Leptin and adiponectin can be more relevant to atherosclerosis in subjects with obesity and diabetes mellitus than conventional atherosclerotic factors such as bp and lipid levels . |
| PubMedID- 24804267 | The mean car.int-r and car.int-l values, which were recognized as one of the important markers of atherosclerosis, of patients with diabetes are significantly higher than the control group (p < 0.01, for each). |
| PubMedID- 22367281 | Low ghrelin serum levels were associated with advanced carotid atherosclerosis in patients with type ii diabetes mellitus15 and elderly patients with metabolic syndrome16, implicating the role of ghrelin as a novel atherosclerotic biomarker and predictive index of atherosclerosis. |
| PubMedID- 21270185 | Research design and methods: the japanese primary prevention of atherosclerosis with aspirin for diabetes (jpad) trial was a prospective, randomized, open-label trial conducted throughout japan that enrolled 2,539 type 2 diabetic patients without a history of atherosclerotic diseases. |
| PubMedID- 23230750 | According to the levels of cimt, 64 diabetic patients were classified into two groups: diabetes mellitus without atherosclerosis (a group, n = 37) and diabetes mellitus with atherosclerosis (b group, n = 27). |
| PubMedID- 24331102 | Conclusion: controlling abdominal obesity seems to have a significant impact on the progression of subclinical atherosclerosis in patients with diabetes, and therefore, more efforts should be made toward reducing waist circumference to inhibit overt atherosclerotic diseases. |
| PubMedID- 22210567 | To better elucidate the role of type 1 diabetes in atherosclerosis, we excluded patients with type 2 diabetes and used as a control group of uremic patients without diabetes. |
| PubMedID- 24843652 | These results suggest that the losartan/imidapril combination might be useful to prevent the progression of atherosclerosis and nephropathy in patients with type 2 diabetes by exerting anti‐inflammatory and anti‐oxidative effects through inhibition of the ras. |
| PubMedID- 24101925 | It has been reported that metabolic syndrome and insulin resistance are the major components of atherosclerosis risk in patients with diabetes and also in individuals without diabetes with insulin resistance , whereas the role of hyperglycemia in cardiovascular disease associated with type 2 diabetes is less clear . |
| PubMedID- 20807873 | atherosclerosis is accelerated in patients with type 2 diabetes and underlies their higher incidence of cardiovascular disease (cvd) events. |
| PubMedID- 24599017 | The aim of this study was to assess whether the iad could be a marker for subclinical atherosclerosis in patients with type 2 diabetes who are at high risk of cardiovascular disease (cvd). |
| PubMedID- 21747057 | Background: endothelial dysfunction contributes to the development of atherosclerosis in patients with diabetes mellitus, but the mechanisms of endothelial dysfunction in this setting are incompletely understood. |
| PubMedID- 20134102 | Genetic risk factors and the anti-atherosclerotic effect of pioglitazone on carotid atherosclerosis of subjects with type 2 diabetes--a retrospective study. |
| PubMedID- 25537059 | Background: we aimed to investigate the association of toenail onychomycosis with subclinical atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 21911774 | Dyslipidemia, one risk factor for atherosclerosis, frequently is associated with diabetes and increases the risk of cardiovascular disease (22). |
| PubMedID- 20357380 | diabetes is associated with accelerated atherosclerosis and an increased risk of cardiovascular disease (cvd), which has become the major cause of morbidity and mortality among patients with diabetic nephropathy (1). |
| PubMedID- 21957962 | This may contribute to atherosclerosis in diabetes mellitus. |
| PubMedID- 24282628 | In the last decades, the pandemic of overweight and obesity related to sedentary lifestyle and excess intake of refined foods has led to a dramatic rise in the prevalence of the metabolic syndrome and associated conditions, such as type 2 diabetes and dyslipidemia, leading to accelerated atherosclerosis . |
| PubMedID- 23844137 | The expression of the age receptor rage is upregulated in endothelial cells, smooth muscle cells, and mononuclear phagocytes in diabetic vasculature, and such upregulation is linked to the inflammatory response , , and it accelerates the development of atherosclerosis in patients with diabetes . |
| PubMedID- 23695772 | Conclusions: treatment with either aliskiren or amlodipine did not significantly alter surrogate biomarkers of atherosclerosis in patients with both diabetes and established cardiovascular disease already receiving appropriate secondary cardiovascular prevention therapy. |
| PubMedID- 23387219 | Objective: to investigate whether serum cystatin c (cys c) concentration correlates with the severity of carotid atherosclerosis (cas) in patients with type 2 diabetes mellitus (dm). |
| PubMedID- 23761984 | The cross-linking activity is aimed at stabilizing the interaction of microtubules with the plasma membrane, demonstrating that transglutaminase activity can affect protein secretion and matrix deposition in osteoblasts.54,55 fxiii has been shown to have a direct role on vascular endothelial cells in promoting angiogenesis in vitro and in vivo on animal models.56 insulin resistance and diabetes mellitus is associated with prothrombotic states, atherosclerosis, dyslipidemia, and obesity. |
| PubMedID- 23533715 | The underlying mechanisms that cause accelerated atherosclerosis in patients with diabetes and consequently an increased prevalence of cvd are poorly understood. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) , in subjects with early asymptomatic carotid atherosclerosis , and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis . |
| PubMedID- 20414371 | To date, the mcp-1 –2518 a>g polymorphism has been associated with coronary artery disease, nonfamilial idiopathic dilated cardiomyopathy, carotid atherosclerosis in patients with type 2 diabetes, myocardial infarction, ischemic heart disease, and hypertension . |
| PubMedID- 21738343 | To verify the relationship between the mets score and coronary atherosclerosis in diabetes, we divided the study cohort into two groups based on the presence of diabetes. |
| PubMedID- 21398528 | The mechanism for advanced atherosclerosis in patients with diabetes is almost certainly multifactorial. |
| PubMedID- 24461963 | To date, there is some evidence linking individual risk factors (hypertension ) or markers of subclinical atherosclerosis to poorer motor function, but the combined effect of vascular risk factors remains unknown. |
| PubMedID- 23267397 | pon-1 is dysfunctional due to glycation, reducing its ability to retard ldl and cell membrane oxidation and contributing to the inflammation typical of diabetes, leading to the excess atherosclerosis common in this disease. |
| PubMedID- 20004424 | We investigated the relationship between hemoglobin concentration and various factors as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. |
| PubMedID- 25385870 | It is well known that hyperglycemia is a trigger of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 25708055 | In conclusion, cumulative active and passive smoking exposures are significant risk factors for carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 21996253 | Aims: to analyze the relationship between serum levels of osteocalcin and parameters of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25619262 | explored aspects of nadph oxidase c242t polymorphism in pathogenesis of carotid atherosclerosis in patients with type 2 diabetes, and found no significant association of c242t polymorphism in the nadph gene with clinical parameters, including plaque score and intima-media thickness of the carotid artery, using the 75th percentile of intima-media thickness as a cut-off value. |
| PubMedID- 24476202 | Early recognition of asymptomatic atherosclerosis in diabetes would be certainly important in reducing the risk of diabetic macrovascular complication and improvement of the prognosis. |
| PubMedID- 21605345 | Diabetic cardiomyopathy is a clinical condition diagnosed when ventricular dysfunction develops in patients with diabetes devoid of coronary atherosclerosis and hypertension. |
| PubMedID- 22267416 | Intima-media thickness and other markers of atherosclerosis in patients with type 2 diabetes and periodontal disease. |
| PubMedID- 24295032 | Disturbances in the autonomic system modulation seem to precede the increase in the thickness of the carotid intima, a predictor of atherosclerosis progression in patients with type 2 diabetes . |
| PubMedID- 21545576 | Increasing evidence indicates that resistin plays important regulatory roles apart from its role in insulin resistance and diabetes in a variety of biological processes: atherosclerosis and cardiovascular disease (cvd), non-alcoholic fatty liver disease, autoimmune disease, malignancy, asthma, inflammatory bowel disease and chronic kidney disease. |
| PubMedID- 22827403 | The aim of our study was to evaluate serum amyloid a (saa), an acute phase reactant, and carotid intima-media thickness (cimt) as a valid predictor of atherosclerosis in women with gestational diabetes mellitus (gdm). |
| PubMedID- 26177483 | Glucagon-like peptide-1 (glp-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (t2d). |
| PubMedID- 26388951 | Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in type 2 diabetes (boat2 study). |